OrbusNeich Medical Group Holdings Limited

Research OrbusNeich Medical Group Holdings Limited (Q8T) on Bullrun: market cap EUR 307.90M, P/E 7.5, dividend yield 8.1%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 307.90M; P/E is 7.5; dividend yield is 8.1%.

Peer valuation comparison

Latest P/E is 7.48x versus a Healthcare sector median of 24.46x (69.4% below).

Latest dividend yield is 8.13% versus a Healthcare sector median of 2.11% (285.3% above).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025USD 180.45MUSD 41.90MUSD 1.15M67.8%n/aUSD 218.70MUSD 3.91MUSD 413.05M
FY2024USD 164.10MUSD 39.72MUSD 1.84M69.8%0.05USD 248.59MUSD 4.20MUSD 393.31M
FY2023USD 153.87MUSD 45.07MUSD 15.55M69.2%0.05USD 255.78MUSD 7.46MUSD 368.40M
FY2022USD 136.82MUSD 18.49MUSD 20.10M67.6%0.03USD 229.15MUSD 4.03MUSD 322.57M
FY2021n/an/an/an/a-0.01n/an/an/a

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 307.90M7.54.7%0.02

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.02 EUR, yield 8.1%.

YearDividends/share
FY20250.03 USD
FY20240.01 USD

About OrbusNeich Medical Group Holdings Limited

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is OrbusNeich Medical Group Holdings Limited's market cap?

OrbusNeich Medical Group Holdings Limited's market capitalization is EUR 307.90M.

What is OrbusNeich Medical Group Holdings Limited's P/E ratio?

OrbusNeich Medical Group Holdings Limited's price-to-earnings (P/E) ratio is 7.5.

Does OrbusNeich Medical Group Holdings Limited pay a dividend?

OrbusNeich Medical Group Holdings Limited has a dividend yield of 8.1%.

What does OrbusNeich Medical Group Holdings Limited do?

OrbusNeich Medical Group Holdings Limited, an investment holding company, engages in the manufacture, trading, sale, and marketing of medical devices/instruments for the treatment of coronary and peripheral vascular diseases. The company offers semi-compliant balloons and scoring balloons for pre-dilatation and lesion preparation, drug-coated balloons and stents for lesion therapy, non-compliant balloons for post-dilatation, and specialty catheters, as well as microcatheters, guide catheter extension, dual therapy, and drug eluting stents.